NCT02945800 2026-04-02Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory SarcomaH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Completed59 enrolled 11 charts
NCT01962103 2019-12-27Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid TumorsCelgenePhase 1/2 Completed107 enrolled 42 charts